glp-1 agonist home delivery clinics Amazon Launches a GLP-1 Program to Make Weight-Loss Medications Easier to Access

FDA just approved orforglipron (Foundayo), Eli Lilly's oral GLP 1 receptor agonist for obesity. In the ATTAIN 1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest Mounjaro (Tirzepatide): How It Works, How to Take It, and Side Effects GoodRx Treatment with incretin based weight loss medications, like GLP 1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation of medications for AUD compared with other ADA 2025 Diabetes Guideline Highlights 1. Individualized First Line Therapy Metformin no longer mandatory as universal first line.Choice depends on patient phenotype + comorbidities: ASCVD, CKD, HF start with SGLT2 inhibitor GLP 1 receptor agonists are transforming diabetes care by improving blood sugar control, supporting weight loss, and reducing cardiovascular risk when used appropriately. Evidence based therapy selection, correct dosing, and patient counseling are